TScan Closes on Series B to Develop Next-Generation Immuno-Oncology TherapiesAllbiopro2019-07-25T23:30:42+09:007월 25th, 2019|
Pfizer’s Rituxan Biosimilar Gets Thumbs-Up from FDA for Multiple IndicationsAllbiopro2019-07-25T23:29:40+09:007월 25th, 2019|
2019 FDA Warning Letters in the BioPharma Industry So FarAllbiopro2019-07-25T23:29:07+09:007월 25th, 2019|
FDA Advisory Committee Cancels Review of Intra-Cellular’s Schizophrenia DrugAllbiopro2019-07-25T23:28:38+09:007월 25th, 2019|
Biopharma and Intellectual Property: Protecting One of America’s Great Economic EnginesAllbiopro2019-07-25T23:28:03+09:007월 25th, 2019|
Freenome Secures $160 Million to Advance Cancer Detection Blood TestAllbiopro2019-07-25T23:27:31+09:007월 25th, 2019|
Publicis castoffs, reborn as Amplity, look to add comms, data insights to lineupAllbiopro2019-07-25T23:26:57+09:007월 25th, 2019|
Incyte rolls regional TV ads to help patients track PV symptoms before doc visitsAllbiopro2019-07-25T23:26:23+09:007월 25th, 2019|
Content matters: GSK, Novo show how pharma can spark up content marketingAllbiopro2019-07-25T23:25:52+09:007월 25th, 2019|
With pharma-consumer split in its sights, GSK hands chairman seat to SymondsAllbiopro2019-07-25T23:24:49+09:007월 25th, 2019|
Among recent megamergers only AbbVie-Allergan looks like a winner: analystAllbiopro2019-07-25T23:24:18+09:007월 25th, 2019|
Can new Dovato data jump-start uptake of 2-drug HIV regimen? ViiV hopes soAllbiopro2019-07-25T23:23:46+09:007월 25th, 2019|
Another win for Vascepa: Pricing watchdog ICER calls Amarin’s fish-oil pill cost-effectiveAllbiopro2019-07-25T23:23:16+09:007월 25th, 2019|
Biogen keeps its foot on the pedal in biosims as Humira copycat takes ‘market-leading’ positionAllbiopro2019-07-25T23:22:42+09:007월 25th, 2019|
GSK withstands Advair generics, thanks to new respiratory meds and ShingrixAllbiopro2019-07-25T23:22:09+09:007월 25th, 2019|
FDA calls off AdComm for Intra-Cellular’s schizophrenia prospectAllbiopro2019-07-25T23:21:35+09:007월 25th, 2019|
